Rivastigmine transdermal patch is an innovative drug for the treatment of Alzheimer's disease, and has attracted much attention from the medical community and patient groups. Its unique transdermal administration method aims to provide patients with a more convenient and effective treatment plan.

Pharmacological effects of rivastigmine transdermal patch

Rivastigmine transdermal patch is an innovative drug for the treatment of Alzheimer's disease, and its pharmacological effects have attracted much attention. Understanding the pharmacological effects of this drug will help patients more accurately judge its therapeutic effect:

1. Cholinesterase inhibition

Rivastigmine transdermal patch inhibits the activity of cholinesterase and reduces the degradation of acetylcholine, thereby increasing the level of acetylcholine in the brain. Acetylcholine is a neurotransmitter and is particularly important for maintaining normal cognitive function.

2. Improve cognitive function

As the level of acetylcholine increases, rivastigmine transdermal patch can significantly improve the patient's cognitive function, including memory, attention, orientation and language ability. This is undoubtedly an important treatment option for patients with Alzheimer's disease.

Rivastigmine transdermal patch improves patients' cognitive function by inhibiting the activity of cholinesterase and increasing the level of acetylcholine in the brain. This pharmacological mechanism provides new ideas and methods for the treatment of Alzheimer's disease.

Storage method of rivastigmine transdermal patch

The correct storage method is the key to ensuring the efficacy of rivastigmine transdermal patch. Understanding and mastering the storage method of this drug will help patients use the drug better:

1. Temperature and humidity control

Rivastigmine transdermal patch should be stored in a light-proof, sealed, dry place. The recommended storage temperature is 20°C to 25°C, and the allowable temperature range is 15°C to 30°C. Changes in humidity may also have a negative impact on the stability of the drug, and it should be stored in a dry and well-ventilated place.

2. Avoid extreme environments

Avoid exposing rivastigmine transdermal patch to extremely high or low temperatures, such as strong sunlight, sauna or freezing environment. These extreme environments may cause changes in the structure and efficacy of the drug, thereby affecting its therapeutic effect.

The storage method of rivastigmine transdermal patch is very important. It should be stored in a light-proof, sealed, dry place with appropriate temperature. Avoid damage to the drug in extreme environments. Mastering the correct storage method will help patients use the drug better and improve the treatment effect.